Cargando…
Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors
Plaque psoriasis is a systemic immune-mediated disease driven by interleukin-17 producing cells under the regulation of interleukin-23. Interleukin-23 signaling is mediated by the intracellular kinase tyrosine kinase 2, a Janus kinase family member. Tyrosine kinase 2 is a potential target for oral s...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884727/ https://www.ncbi.nlm.nih.gov/pubmed/36592300 http://dx.doi.org/10.1007/s13555-022-00878-9 |